The Russell 2000 index, which represents small-cap companies, outperformed the “Mag 7” stocks over the past month with 1.68% ...

AI isn’t neutral in women’s health. It involves learning from visibility gaps shaped by brand safety, search authority, and ...

AI companies such as OpenAI and Anthropic have long focused on building tools that can write code that will speed up software ...

The Arts Council of Princeton (ACP) has announced a three-person exhibition, “Divergent Forms,” featuring the work of artists ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

XOMA Royalty (XOMA) and Takeda (TAK) stock in focus as the companies ink a new royalty deal and armed an existing agreement.

DNA Ginkgo Bioworks Holdings, Inc.

The new major version with a new JIT compiler, a revised parallelization API, and a maturing type system paves the way for ...